Monthly Archives: May 2025

We are looking for someone who is passionate about community pharmacy and interested in the important work that Local Pharmaceutical Committees (LPCs) do, to join our LPC and Pharmacy Owner Support Team. The team is expanding to include the new post of LPC Engagement and Support Manager, which has been created to enhance the support [...]

The post Job Vacancy: Join our LPC and Pharmacy Owner Support Team appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Notification: Mercaptopurine 50mg Tablets (Aspen Pharma Trading Limited) Drug alert number: EL(25)A/23 Date issued: 22 May 2025 Aspen Pharma Trading Limited is recalling a specific batch of Mercaptopurine 50mg tablets as a precautionary measure due to microbial contamination following a small number of complaints of discoloured tablets within the packs, identified [...]

The post MHRA Class 2 Medicines Recall: Mercaptopurine 50mg Tablets (Aspen Pharma Trading Limited) appeared first on Community Pharmacy England.

Pharmacy teams should be aware that the brand Nystan® 100,000units/ml oral suspension (ready mixed) (Vygoris Ltd) 30 ml has been discontinued and is no longer available for community pharmacies to order. Zydus Pharmaceuticals UK Ltd has introduced a generic version of Nystatin 100,000units/ml oral suspension, which is available to order from wholesalers. Please note, where [...]

The post Discontinuation of Nystan® 100,000units/ml oral suspension (ready mixed) (Vygoris Ltd) appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Tolterodine 2mg and 4mg modified-release capsules MSN/2025/032 Tier 2 – medium impact Date of issue: 20th May 2025 Phenobarbital 15mg/5ml elixir (500ml) is out of stock until late June 2025. Specials of phenobarbital 15mg/5ml oral solution and phenobarbital 15mg/5ml oral suspension [...]

The post Medicine Supply Notification: Phenobarbital 15mg/5ml elixir appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Tolterodine 2mg and 4mg modified-release capsules MSN/2025/031 Tier 2 – medium impact Date of issue: 20th May 2025 Tolterodine 2mg and 4mg modified-release (MR) capsules are in limited supply until mid-August and mid-September 2025, respectively. Tolterodine 1mg and 2mg immediate release [...]

The post Medicine Supply Notification: Tolterodine 2mg and 4mg modified-release capsules appeared first on Community Pharmacy England.